A6. Drugs in liver disease Flashcards

1
Q

Describe drug induced liver disease

A

-Some medicines can result in acute liver damage or cholestasis
-Monitoring of liver function is essential with these medicines
-Baseline LFTs should be taken & then further monitoring as required
-Schedule of this monitoring often listed in the BNF monograph
-Some medicines can result in hepatic enzyme induction OR inhibition
-Liver injury can be predictable & dose-dependent OR idiosyncratic
(unpredictable, occurs at a lower incidence)
-ALWAYS consider possible contribution of drugs in a patient with any type of liver damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drugs which can cause liver damage

A

one note

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

patient factors to consider in liver disease?

A

-Signs & symptoms
-LFTs
-Diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drug factors to consider in liver disease

A

-Pharmacokinetics
-Pharmacodynamics
-Side effect profile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe drug handling in liver disease

A

-Liver is the main site of drug
metabolism
-Hepatic metabolism is most
important for lipid-soluble
drugs whereas water-
soluble drugs are readily
renally excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Many medications undergo what two stage metabolic process?

A

-Phase 1 involves metabolism (oxidation, reduction, hydrolysis)
e.g. cytochrome P450 enzymes (CYP450)
-Phase 2 includes biotransformation with conjugation of the drug or its
metabolites, examples of phase 2 pathways
e.g. glucuronidation and sulphation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe CYP-mediated reactions

A

-CYP-mediated reactions are affected more in liver disease
than phase 2 reactions
-Expression of CYP 1A, 2C19 and 3A are decreased in cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the inhibition and induction in alcoholic liver disease

A

one note

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Changes in absorption in liver disease

A

-Decreased gut motility in cirrhosis means a delay in gastric emptying,
and a reduction in the rate, but not extent of absorption
-Reduced absorption & bioavailability of lipophilic drugs may occur with
cholestasis
-Drugs which have a low bioavailability due to high first pass metabolism may need dose reducing in liver disease due to an
increased bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Distribution changes in liver disease

A

-Ascites increases the volume of distribution for water
soluble drugs e.g. gentamicin, which leads to a
reduced drug concentration
-Ascites: build-up of fluid in the space between
lining of the abdomen and abdominal organs
-Low albumin levels may mean drugs which are
highly protein bound (phenytoin) usually are at a
higher concentration of free drug, potentially leading
to toxicity
-Excess bilirubin can displace highly protein bound
drugs from their binding sites → more free drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

metabolism changes in liver disease

A

-Impaired liver metabolism only occurs in severe disease (liver tissue has excellent
reserves)
-Reduced hepatic blood flow in cirrhosis due to portosystemic shunting (less
blood flows through liver, and moves to systemic circulation)
-Reduced hepatic clearance increases drug levels & toxicity → causes issues for
drugs with a narrow therapeutic window
-Prodrugs that need to be metabolise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

elimination/ excretion changes in liver disease

A

-Renal excretion can be reduced in patients with severe liver
disease
-Hepatorenal syndrome
-CrCl may be overestimated in patients with cirrhosis
-Reduced serum creatinine if reduced muscle mass and
reduced conversion of creatine to creatinine in the liver
-If a drug is excreted in the bile, if the patient has cholestasis, this process will be reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drug factors to think about in liver disease

A

-Hydrophilic or lipophilic?
-Protein bound?
-Does it displace bilirubin? Or is it displaced?
-Is it metabolised by the liver?
-Does it have a high extraction ratio?
-Is it potentially hepatotoxic?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Some common examples of medications you will need to be aware of reducing/avoiding in liver disease are:

A

-Constipating drugs
-Sedating drugs
-Drugs that lower seizure threshold
-Drugs which increase the risk of GI ulceration and bleeding
-Drugs which cause endocrine/metabolic changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe constipating drugs in liver disease and example drugs?

A

-Medicines which can cause constipation (see Drugs in GI diseases lecture) can precipitate or worsen hepatic encephalopathy in patients with liver disease.
-Accumulation of toxic waste products can cross the blood-brain barrier
-HE is defined as a spectrum of neuropsychiatric abnormalities in patients with liver dysfunction
-Example drugs: loperamide, codeine, amitriptyline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to treat constipation in liver disease?

A

Laxatives such as lactulose can be co-prescribed, this can also be used to prevent/treat encephalopathy

17
Q

Sedating drugs in liver disease?

A

-Avoid in patients at risk of HE as the brain is more sensitive to sedating effects
-Sedation & confusion will increase risk or worsen HE
-Example drugs: opioids, sedating antihistamines, tricyclic antidepressants

18
Q

Drugs which reduce seizure threshold in Liver disease? examples?

A

-Some drugs have an increased risk of convulsions
-Patients who struggle with excessive alcohol consumption are at an increased risk of seizures due to withdrawal
-Example drugs: tramadol, pethidine, sedating antihistamines, antipsychotics and antidepressants

19
Q

Drugs which increase GI ulceration in Liver disease? examples?

A

-Risk in patients with portal hypertension, varices, low platelets & deranged
clotting
-Integrity of GI mucosa may already be compromised by excessive alcohol →
increased GI ulceration risk
-Vitamin K & clotting factor synthesis may be impaired
-Example drugs: clopidogrel, warfarin, corticosteroids, SSRIs

20
Q

NSAIDs are C/I in patients with any degree of liver cirrhosis due to SEs:

A

-Fluid retention (patient already may have ascites)
-Electrolyte abnormalities
-Gastrointestinal ulceration & bleeding
-Inhibition of platelet aggregation
-Reduction in glomerular filtration

21
Q

what are oesophageal varices?

A

-Varices are expanded blood vessels that develop most commonly in the oesophagus and stomach
-More common in people with cirrhosis

22
Q

How do oesophageal varices develop?

A

Develop when blood flow through the liver is obstructed (blocked) by scarring, increasing the pressure inside the
portal vein, which carries blood from the intestines to the liver → portal hypertension

23
Q

What can portal hypertension lead to?

A

-Portal hypertension leads to an increase in the blood pressure inside the veins
-Veins expand under higher pressure resulting in varices
-Managed pharmacologically with terlipressin, & reducing PV hypertension or surgically with banding

24
Q

Drugs which can cause endocrine/metabolic changes?

A

-Diuretics can cause hyponatraemia & hypokalaemia → encephalopathy
-As discussed on previous slide NSAIDs can increase sodium & water retention → worsening ascites, precipitating renal
failure
-Medicines with a high sodium content e.g. antacids, soluble tablets can also precipitate/worsen ascites

25
Drugs to review in liver disease?
Generally, patients with pre-existing liver disease are thought to be at no greater risk of drug-induced liver damage than the general population. Exceptions: Methotrexate & Rifampicin
26
Describe paracetamol and the liver
-Reduced clearance in liver impairment -Most evidence suggests still safe to use in majority of patients with liver disease at normal doses -Weight <50kg 500mg QDS max -Weight >50kg 1g QDS max -However, in active liver disease use is often more cautionary with max 3g/24 hr -Overdose risk is difficult to predict – as little as 10 tablets in 24 hours can cause liver toxicity in a patient at high risk of liver damage -Symptom onset is often later than expected
27
Describe Paracetamol Overdose & Acetylcysteine
-Nausea and vomiting are often the early features which usually settle -Liver damage is maximal 3-4 days after the overdose and may lead to encephalopathy, haemorrhage and death -Acetylcysteine protects the liver if given within 24 hours (ideally 8 hours) -Patients needing treatment can be identified by measurement of plasma- paracetamol concentration related to time -Acetylcysteine given as three infusions (varied doses) over 21 hours – see BNF -Patients at high risk of liver damage include those of low body weight, who are malnourished, take enzyme inducing drugs and have also taken alcohol -Determine if acute or staggered overdose
28
pharmacists role in supporting patients with liver disease?
one note